Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Human T-lymphotropic Virus 2”

7 trials

Showing 7 of 7 results

Post-approval studies (Phase 4)Study completedNCT03226119
What this trial is testing

MP Diagnostics HTLV Blot 2.4 Post-Market Clinical Study

Who this might be right for
HTLV-I InfectionsHTLV-II InfectionsHuman T-lymphotropic Virus 1+3 more
MP Biomedicals, LLC 150
Not applicableStudy completedNCT01149837
What this trial is testing

Evaluation of InnoLIA HTLV I/II Score

Who this might be right for
Human T-Lymphotrophic Virus Type I and/or Type II
Creative Testing Solutions 3,305
Not applicableStudy completedNCT00097006
What this trial is testing

Retrovirus Epidemiology Donor Study-II (REDS-II)

Who this might be right for
Acquired Immunodeficiency SyndromeBlood DonorsBlood Transfusion+10 more
National Heart, Lung, and Blood Institute (NHLBI)
Not applicableStudy completedNCT03146013
What this trial is testing

Dual Algorithm Post Market Clinical Study

Who this might be right for
HTLV-I InfectionsHTLV-II InfectionsHuman T-lymphotropic Virus 1+3 more
MP Biomedicals, LLC 100
Not applicableUnknownNCT01467024
What this trial is testing

Evaluation of the MP Diagnostics HTLV Blot 2.4

Who this might be right for
HTLV-I InfectionsHTLV-II InfectionsHuman T-lymphotropic Virus 1+3 more
MP Biomedicals, LLC 600
Not applicableStudy completedNCT00005278
What this trial is testing

Retrovirus Epidemiology Donor Study I (REDS I)

Who this might be right for
Acquired Immunodeficiency SyndromeBlood DonorsBlood Transfusion+6 more
National Heart, Lung, and Blood Institute (NHLBI)
Testing effectiveness (Phase 2)Ended earlyNCT01712659
What this trial is testing

Ruxolitinib for Adult T-Cell Leukemia

Who this might be right for
T Cell Leukemia, AdultLeukemia, Adult T-CellT Cell Leukemia, HTLV I Associated
National Cancer Institute (NCI) 19

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation